TIP_link_300x300.jpg
Peptide Therapeutics Market to Outstrip $50,003.15 Million by 2027 Growing Sturdy at 9.2% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
June 09, 2021 11:13 ET | The Insight Partners
Pune, India., June 09, 2021 (GLOBE NEWSWIRE) -- Peptide Therapeutics Market: Key InsightsAccording to our new research study on “Peptide Therapeutics Market to 2027 – Global Analysis and Forecast –...
photo1
Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board
January 06, 2021 18:00 ET | Peptomyc S.L.
BARCELONA, Spain, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Peptomyc S.L., a biotech company specialized in the development of protein and peptide therapeutics targeting the Myc oncoprotein for cancer...
logo.jpg
Global Peptide Therapeutics Market Size Growth Forecast Sales Clinical Trials Insight 2026
November 11, 2020 03:36 ET | KuicK Research
DELHI, India, Nov. 11, 2020 (GLOBE NEWSWIRE) -- “Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026” report highlights: Global Peptide Therapeutics Market Opportunity: US$ 65...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process
June 10, 2020 02:00 ET | Zealand Pharma
Press Release – No. 07 / 2020 Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process The research agreement enhances Zealand Pharma’s...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics
October 22, 2019 06:05 ET | Zealand Pharma
Company announcement – No. 37 / 2019 Zealand Pharma expands its peptide platform with acquisition of Encycle Therapeutics                The transaction strengthens the leadership of Zealand Pharma...